BILL ANALYSIS                                                                                                                                                                                                    �



                                                                  AB 686
                                                                  Page  1

          Date of Hearing:   May 24, 2013

                        ASSEMBLY COMMITTEE ON APPROPRIATIONS
                                  Mike Gatto, Chair

                      AB 686 (Quirk) - As Amended:  May 7, 2013 

          Policy Committee:                              Environmental  
          Safety       Vote:                            7-0

          Urgency:     No                   State Mandated Local Program:  
          No     Reimbursable:              

           SUMMARY  

          This bill requires the Department of Toxic Substance Control  
          (DTSC) to develop recommendations for standards and guidelines  
          for the operation of on-site hazardous waste management and  
          recycling pharmaceutical manufacturing and processing  
          facilities.  The report is required to be submitted by January  
          1, 2015 and identify any necessary statutory or regulatory  
          actions as specified.

           FISCAL EFFECT  

          1)Increased costs to DTSC from the Hazardous Waste Control  
            Account (HWCA) or GF in the $100,000 to $200,000 range.

            Expenditures and revenues in the HWCA account are currently  
            about equal.  While the account carries a small surplus, it is  
            used to pay monthly costs.   It is unlikely DTSC would be able  
            to absorb this additional expenditure without a fee increase  
            or GF appropriation.
           
           COMMENTS  

           1)Purpose.   The author originally intended this bill to exempt  
            specified waste material from pharmaceutical manufacturing  
            used for cogeneration fuels from hazardous waste permitting  
            requirements if the manufacturer complies with the standards  
            under the Federal Resource Conservation and Recovery Act.  As  
            amended in the Environmental Safety Committee, the bill  
            instead requires DTSC to study the issue and make  
            recommendations to the Legislature.  









                                                                 AB 686
                                                                  Page  2

          2)Existing California law allows for hazards waste treatment  
            permits  .  Pharmaceutical manufacturing facilities must  
            currently receive DTSC hazardous waste permits for treatment  
            or storage of hazardous waste, including those proposed to be  
            burned. According to DTSC, the sponsors of this legislation  
            have the option of seeking a hazardous waste treatment  
            facility permit for the treatment of the hazardous waste at  
            the manufacturing site.  To date, no permit applications have  
            been submitted by any pharmaceutical manufactures.  

           
           Analysis Prepared by  :    Jennifer Galehouse / APPR. / (916)  
          319-2081